CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Enteropathy-Associated T-Cell Lymphoma

A primary peripheral T-cell lymphoma in the gastrointestinal tract, most often in the jejunum, associated with a history of CELIAC DISEASE or other gastrointestinal diseases.

Drugs by status

Phase 4 trials (11)

  • urea
  • prednisone
  • doxorubicin
  • gemcitabine
  • naltrexone
  • epirubicin
  • vincristine
  • ifosfamide
  • cyclophosphamide
  • etoposide
  • pirarubicin

Phase 2 trials (11)

  • azacitidine
  • methylprednisolone
  • brentuximab vedotin
  • duvelisib
  • carmustine
  • tazemetostat
  • cisplatin
  • cytarabine
  • melphalan
  • dr-01
  • golidocitinib

Phase 1 trials (7)

  • alisertib
  • cd30-car t cells
  • fludarabine
  • romidepsin
  • cd7 car-t cell
  • wu-cart-007
  • autologous ccr4 car t cells

Other trials (2)

  • vitamin d3
  • chia seed

Organizations

Organization Involved with Phase 4 Indications (2)

  • Shandong Provincial Hospital
  • Jiao Tong University

Organization Involved with Phase 2 Indications (14)

  • PersonGen BioTherapeutics (Suzhou) Co., Ltd.
  • Imagine Institute
  • National Cancer Institute (NCI)
  • Case Western Reserve University
  • Cancer Research UK
  • Singapore General Hospital
  • University of Melbourne
  • University of Nebraska
  • University of Rochester
  • Mayo Clinic
  • Royal Marsden Hospital NHS Trust
  • City of Hope National Medical Center
  • University of Paris
  • Hefei University

Organization Involved with Phase 1 Indications (4)

  • Celgene
  • Millennium Pharmaceuticals
  • Zhengzhou University
  • University of Texas at Houston

ICD-10 crosswalk

  • C86.2 — Enteropathy-type (intestinal) T-cell lymphoma

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.